Correlation Between Pfizer and Fuse Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Fuse Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Fuse Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Fuse Science, you can compare the effects of market volatilities on Pfizer and Fuse Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Fuse Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Fuse Science.

Diversification Opportunities for Pfizer and Fuse Science

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pfizer and Fuse is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Fuse Science in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fuse Science and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Fuse Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fuse Science has no effect on the direction of Pfizer i.e., Pfizer and Fuse Science go up and down completely randomly.

Pair Corralation between Pfizer and Fuse Science

Considering the 90-day investment horizon Pfizer is expected to generate 14.52 times less return on investment than Fuse Science. But when comparing it to its historical volatility, Pfizer Inc is 12.3 times less risky than Fuse Science. It trades about 0.11 of its potential returns per unit of risk. Fuse Science is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.19  in Fuse Science on May 9, 2025 and sell it today you would earn a total of  0.14  from holding Fuse Science or generate 73.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.41%
ValuesDaily Returns

Pfizer Inc  vs.  Fuse Science

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in September 2025.
Fuse Science 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fuse Science are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Fuse Science reported solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Fuse Science Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Fuse Science

The main advantage of trading using opposite Pfizer and Fuse Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Fuse Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fuse Science will offset losses from the drop in Fuse Science's long position.
The idea behind Pfizer Inc and Fuse Science pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital